Patents Assigned to SPRINT BIOSCIENCE AB
  • 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes
    Patent number: 11179399
    Abstract: The invention provides novel 6-heterocyclyl-4-morpholin-4-yl-pyridine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and A are as defined in the specification.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: November 23, 2021
    Assignee: SPRINT BIOSCIENCE AB
    Inventors: Jessica Martinsson, Martin Andersson, Johan Lindström, Rickard Forsblom, Fredrik Rahm, Tobias Ginman, Jenny Viklund
  • 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
    Patent number: 11077113
    Abstract: The invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: August 3, 2021
    Assignee: SPRINT BIOSCIENCE AB
    Inventors: Jessica Martinsson, Martin Andersson, Johan Lindström, Rickard Forsblom, Fredrik Rahm, Tobias Ginman, Jenny Viklund